Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Minimed Group's Enterprise Value is $4,011 Mil.
Minimed Group's EBIT for the trailing twelve months (TTM) ended in Jan. 2026 was $-131 Mil. Therefore, Minimed Group's EV-to-EBIT ratio for today is -30.62.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Minimed Group's Enterprise Value is $4,011 Mil.
Minimed Group's EBITDA for the trailing twelve months (TTM) ended in Jan. 2026 was $-54 Mil. Therefore, Minimed Group's EV-to-EBITDA ratio for today is -74.28.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Minimed Group's Enterprise Value is $4,011 Mil.
Minimed Group's Revenue for the trailing twelve months (TTM) ended in Jan. 2026 was $1,514 Mil. Therefore, Minimed Group's EV-to-Revenue ratio for today is 2.65.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Minimed Group's Enterprise Value is $4,011 Mil.
Minimed Group's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2026 was $39 Mil. Therefore, Minimed Group's EV-to-FCF ratio for today is 102.85.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Minimed Group (NAS:MMED) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Minimed Group's current Enterprise Value is $4,011 Mil.
Minimed Group's EBIT for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-131 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Minimed Group's current Enterprise Value is $4,011 Mil.
Minimed Group's EBITDA for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-54 Mil.
Minimed Group's current Enterprise Value is $4,011 Mil.
Minimed Group's Revenue for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,514 Mil.
Minimed Group's current Enterprise Value is $4,011 Mil.
Minimed Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $149 Mil.
Minimed Group's current Enterprise Value is $4,011 Mil.
Minimed Group's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $39 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Minimed Group Enterprise Value Related Terms
Minimed Group Enterprise Value Historical Data
* Premium members only.
The historical data trend for Minimed Group's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Minimed Group Enterprise Value Chart
Minimed Group Annual Data
Trend
Apr23
Apr24
Apr25
Enterprise Value
0.00
0.00
0.00
Minimed Group Quarterly Data
Apr24
Jan25
Apr25
Oct25
Jan26
Enterprise Value
0.00
0.00
0.00
0.00
0.00
MMED vs ICUI, WRBY, MMSI: Enterprise Value Comparison
For the Medical Instruments & Supplies subindustry, Minimed Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Minimed Group Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Minimed Group's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Minimed Group's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Minimed Group's Enterprise Value for the fiscal year that ended in Apr. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Minimed Group (MMED) has a Enterprise Value of $4,011 Mil as of Jun. 27, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Minimed Group and its competitors.
Is Minimed Group's Enterprise Value too high?
Minimed Group's current Enterprise Value is $4,011 Mil. Overall, Minimed Group has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Minimed Group's Enterprise Value compare to ICUI and WRBY?
Minimed Group's Enterprise Value of $4,011 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Minimed Group and its competitors. Minimed Group's current Enterprise Value is $4,011 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minimed Group stock overvalued right now?
Minimed Group (MMED) has a current Enterprise Value of $4,011 Mil. The current Enterprise Value is $4,011 Mil. Minimed Group's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Minimed Group (MMED), the current Enterprise Value is $4,011 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
15GF Score
Get the complete analysis for MMED
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MMED has been successfully added to your 